Theorem Clinical Research

Bill & Melinda Gates Foundation

Gates Foundation commits $50M to support emergency response to Ebola

Friday, September 12, 2014 01:13 PM

The Bill & Melinda Gates Foundation plans to commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus.

More... »


Kymab receives $40M investment from Wellcome Trust, Gates Foundation

Monday, May 19, 2014 01:25 PM

The Bill & Melinda Gates Foundation and the Wellcome Trust each invested $20 million in Kymab, a monoclonal antibody biopharmaceutical company, to enable Kymab to maximize its Kymouse platform and advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies in areas of significant unmet medical need, including cancer and inflammation.

More... »


Critical Path Institute receives grant for tuberculosis treatments

Wednesday, February 12, 2014 01:31 PM

The Critical Path Institute, an independent nonprofit that catalyzes innovative ideas to accelerate the speed of drug and medical product development, has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop quantitative mathematical models to optimize the design of clinical trials and tackle challenges facing the development of effective tuberculosis (TB) treatments.  

More... »

G-FINDER report: Governments cutting funding for neglected disease R&D

Friday, December 13, 2013 02:03 PM

The sixth annual G-FINDER survey reported both good and bad news on global investment into R&D for new neglected disease products. The good news is that global funding for neglected disease R&D totaled $3.2 billion in 2012, thanks to an increase in funding from repeat survey participants of $92.1 million (up 3.2%) over 2011 levels—a positive change as global investment in neglected disease R&D had been declining since 2009. But in 2012, non-U.S. government funding fell by $52.6 million (down 12.4%), with 11 governments cutting or freezing funding. Since the global financial crisis, total investment from this group has fallen by 20% ($90.6 million).

More... »

GSK, Gates Foundation partner for vaccine thermostability

Wednesday, October 30, 2013 11:16 AM

GlaxoSmithKline (GSK) and the Bill & Melinda Gates Foundation (BMGF) have formed a joint initiative to make vaccines more resistant to heat, thus reducing the need for refrigeration. GSK and BMGF will invest a combined $1.8 million in early stage research into vaccine thermostability.

More... »

WHO prequalifies first Chinese-produced vaccine

Friday, October 11, 2013 02:13 PM

A newly accessible vaccine against Japanese encephalitis is going to protect more children in developing countries. The vaccine, manufactured in China, needs to be given in only one dose,  can be used for infants and  is less expensive than other Japanese encephalitis vaccines.

More... »

Global Health Investment Fund launched for late-stage vaccines

Friday, September 27, 2013 10:59 AM

A new investment fund structured by JPMorgan Chase and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

More... »

Bill Gates, Tenaya Capital invest in ResearchGate

Friday, June 7, 2013 01:58 PM

ResearchGate, a professional network for scientists, has a new investment from Bill Gates and Tenaya Capital with participation from Dragoneer Investment Group, Thrive Capital and the company's existing investors Benchmark and Founders Fund.

More... »

Japan screening massive drug compound libraries for new treatments

Wednesday, June 5, 2013 01:32 PM

The Global Health Innovative Technology Fund (GHIT Fund), a public-private partnership focused on Japanese R&D related to infectious disease, will make a series of agreements to screen compound libraries at Japanese pharmaceutical companies and research institutes for new treatments for malaria, tuberculosis and other afflictions.

More... »

Japan establishes global fund for R&D of new medicines, vaccines, diagnostics

Wednesday, April 10, 2013 10:15 AM

Japan’s first public-private partnership to advance the development of new health technologies for the developing world The Global Health Innovative Technology Fund (GHIT Fund) has officially launched. The GHIT Fund has been established to advance the R&D of new medicines, vaccines and diagnostics to fight infectious diseases in the developing world.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs